Norges Bank Frequency Therapeutics, Inc. Transaction History

Norges Bank

  • $655 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 08, 2020
SELL
$16.36 - $27.55 $654,400 - $1.1 Million
-40,000 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$12.67 - $18.73 $506,800 - $749,200
40,000 New
40,000 $701,000

About Frequency Therapeutics, Inc.

FREQ Quotes by TradingView
  • Ticker FREQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,262,000
  • Description
  • Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...
More about FREQ
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email